Silence Therapeutics plc

SLN · XNAS

CIK 1479615fmd_1PKTVE6JZ7XRMMSJZHF3N9CYV0Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2018 to Sep 30, 2026, 17 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.